XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Method Investment In ARO (Tables)
3 Months Ended
Mar. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments
Summarized financial information for ARO is as follows (in millions):
Three Months Ended
March 31, 2022March 31, 2021
Revenues$111.3 $122.7 
Operating expenses
Contract drilling (exclusive of depreciation)84.2 86.3 
Depreciation16.5 16.1 
General and administrative5.2 3.0 
Operating income5.4 17.3 
Other expense, net3.3 4.5 
Provision for income taxes0.7 4.5 
Net income$1.4 $8.3 

March 31,
2022
December 31, 2021
Cash and cash equivalents$240.2 $270.8 
Other current assets179.5 135.0 
Non-current assets775.8 775.8 
Total assets$1,195.5 $1,181.6 
Current liabilities$92.9 $79.9 
Non-current liabilities957.9 956.7 
Total liabilities$1,050.8 $1,036.6 
A reconciliation of those components is presented below (in millions):
SuccessorPredecessor
Three Months Ended March 31, 2022Three Months Ended March 31, 2021
50% interest in ARO net income$0.7 $4.1 
Amortization of basis differences3.6 (2.2)
Equity in earnings of ARO$4.3 $1.9 
The following table summarizes the total assets and liabilities as reflected in our Condensed Consolidated Balance Sheets as well as our maximum exposure to loss related to ARO (in millions). Our maximum exposure to loss is limited to (1) our equity investment in ARO; (2) the carrying amount of our shareholder notes receivable; and (3) other receivables and contract assets from ARO, partially offset by contract liabilities as well as payables to ARO.
March 31, 2022December 31, 2021
Total assets$362.9 $348.1 
Less: total liabilities51.0 49.1 
Maximum exposure to loss$311.9 $299.0 
Schedule of Related Party Transactions
Revenues recognized by us related to the Lease Agreements are as follows (in millions):
SuccessorPredecessor
Three Months Ended March 31, 2022Three Months Ended March 31, 2021
Lease revenue $14.2 $16.6 

(1)    Revenues presented above are included in our Other segment in our segment disclosures. See "Note 12 - Segment Information" for additional information.